[CAS NO. 1051375-19-9]  Dolutegravir Sodium

Ships within Stock Price Qty Total
$0.00
$0.00
Please click "REQUEST A QUOTE" button if you need other sizes or custom synthesis
request a quote
If there is no stock, or you need other sizes or custom synthesis, please:

PRODUCTS SPECIFICATIONS [1051375-19-9]

Store
Catalog
SLK-S4642
Brand
Selleck
CAS
1051375-19-9

DESCRIPTION [1051375-19-9]

Overview

MDL-
Molecular Weight441.36
Molecular FormulaC20H19F2N3O5.Na
SMILESO=C1C=2N(C[C@]3(N1[C@H](C)CCO3)[H])C=C(C(NCC4=C(F)C=C(F)C=C4)=O)C(=O)C2O.[Na]

For research use only.

Storage

3 years,-20°C,powder
1 years,-80°C,in solvent

Shipping

Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.)

Preparing Stock Solutions

1 mg5 mg10 mg
1 mM2.2657 mL11.3286 mL22.6572 mL
5 mM0.4531 mL2.2657 mL4.5314 mL
10 mM0.2266 mL1.1329 mL2.2657 mL
50 mM---

Description

Dolutegravir Sodium (GSK-1349572A) is a inhibitor with of 2.7 nM.

Targets

HIV integrase [1]
(Cell-free assay)
2.7 nM

In vitro

Dolutegravir(S/GSK1349572) inhibits HIV-1 integrase-catalyzed strand transfer with a 50% inhibitory concentration (IC50) of 2.7 nM. S/GSK1349572 inhibits both the HIV integration reaction strand transfer step in vitro and HIV replication in cells with similar potencies. The inhibitor has no effect on total viral DNA synthesis in infected cells but blocks the integration of viral DNA into host DNA with the same potency as its antiviral effect.

In vivo

The bioavailability of dolutegravir was high when administered as a solution, but was limited by dissolution rate or solubility when administered as a suspension. Dolutegravir is the major circulating component in mice, rats, and monkeys, with direct ether glucuronidation shown to be the primary biotransformation pathway. Dolutegravir is primarily eliminated via the feces either unabsorbed or by hydrolysis of the glucuronide or glucose conjugate.


Synonyms

2H-Pyrido[1′,2′:4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide, N-[(2,4-difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, sodium salt (1:1), (4R,12aS)-
Dolutegravir sodium
GSK 1349572A
Dolutegravir sodium salt